Solid-phase synthesis of pyridones and pyridopyrazines as peptidomimetic scaffolds

Organic Letters

Volumn 1, Issue 9, 1999, Pages 1407-1409

  Creighton, Christopher J ^a   Zapf, Christoph W ^a   Bu, Jane H ^a   Goodman, Murray ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PEPTIDE; PYRAZINE DERIVATIVE; PYRIDONE DERIVATIVE;

ARTICLE; CHEMISTRY; MOLECULAR MIMICRY; SYNTHESIS;

MOLECULAR MIMICRY; PEPTIDES; PYRAZINES; PYRIDONES;

EID: 0033523817     PISSN: 15237060     EISSN: None     Source Type: Journal    
DOI: 10.1021/ol990960u     Document Type: Article

References (22)

1. Sawyer, T. K. Peptidomimetic and Nonpeptide Drug Discovery: Impact of Structure-Based Drug Design. In Structure Based Drug Design: Disease, Targets, Techniques and Development; Veerapandian, P., Ed.; Marcel Dekker: New York, 1997; pp 559-634.
2. Hirschmann, R.; Nicolaou, K. C.; Pietranico, S.; Salvino, J.; Leahy, E. M.; Sprengeler, P. A.; Furst, G.; Smith, A. B. J. Am. Chem. Soc. 1992, 114, 9217-9218.
3. Blackburn, B. K.; Lee, A.; Baier, M.; Kohl, B.; Livero, A. G.; Matamoros, R.; Robarge, K. D.; McDowell, R. S. J. Med. Chem. 1997, 40, 717-729.
4. Chang, K.; Rigdon, G. C.; Howard, J. L.; McNutt, R. W. J. Pharm. Exp. Therap. 1993, 267, 852-857.
5. Hanessian, S.; McNaughton-Smith, G.; Lombart, H.; Lubell, W. D. Tetrahedron 1995, 2937-2940.
6. For comprehensive reviews on reactions carried out on the solid phase, see: Hermkens, P. H. H.; Ottenheijm, H. C. J.; Rees, D. Tetrahedron 1996, 4527-4554. Hermkens, P. H. H.; Ottenheijm, H. C. J.; Rees, D. Tetrahedron 1997, 5643-5678. Booth, S.; Hermkens, P. H. H.; Ottenheijm, H. C. J.; Reese, D. C. Tetrahedron 1998, 15385-15443.
7. For comprehensive reviews on reactions carried out on the solid phase, see: Hermkens, P. H. H.; Ottenheijm, H. C. J.; Rees, D. Tetrahedron 1996, 4527-4554. Hermkens, P. H. H.; Ottenheijm, H. C. J.; Rees, D. Tetrahedron 1997, 5643-5678. Booth, S.; Hermkens, P. H. H.; Ottenheijm, H. C. J.; Reese, D. C. Tetrahedron 1998, 15385-15443.
8. For comprehensive reviews on reactions carried out on the solid phase, see: Hermkens, P. H. H.; Ottenheijm, H. C. J.; Rees, D. Tetrahedron 1996, 4527-4554. Hermkens, P. H. H.; Ottenheijm, H. C. J.; Rees, D. Tetrahedron 1997, 5643-5678. Booth, S.; Hermkens, P. H. H.; Ottenheijm, H. C. J.; Reese, D. C. Tetrahedron 1998, 15385-15443.
9. Houghten, R. A.; Nefzi, A.; Ostresh, J. M. Chem. Rev. 1997, 449-472.
10. (a) Kerwin, J. F., Jr.; Danishefsky, S. Tetrahedron Lett. 1982, 23, 3739-3742.
11. (b) Danishefsky, S.; Vogel, C. J. Org. Chem. 1986, 51, 3915-3916.
12. (c) Danishefsky, S. Acc. Chem. Res. 1981, 14, 400-406.
13. Wang, Y.; Wilson, S. R. Tetrahedron Lett. 1997, 4021-4024.
14. Waldmann, H.; Braun, M. J. Org. Chem. 1992, 57, 4444-4451.
15. Szardenings, A. K.; Burkoth, T. S.; Lu, H. H.; Tien, D. W.; Campbell D. A. Tetrahedron 1997, 6573-6593.
16. Romoff, T. T.; Wang, Y. W.; Campbell, D. A. Synlett 1997, 1341-1342.
17. Look, G. C.; Murphy, M. M.; Campbell, D. A.; Gallop, M. A. Tetrahedron Lett. 1995, 2937-29040.
18. (a) Hughes, J.; Smith, T. W.; Kosterlitz, H. W.; Forthergill, L. A.; Morgan, B. A.; Morris, H. R. Nature 1975, 577-579.
19. (b) Morley, J. S. Annu. Rev. Pharmocol. Toxicol. 1980, 81-110.
20. 3 as a catalyst for pyridone formation. A discussion of this study will be published at a later date.
21. 5Na 460.1848, found, 460.1848.
22. 4Na 471.2008, found, 471.1988.